What Researchers Did
Researchers assessed adjunctive HBOT outcomes in 58 patients with chronic refractory osteomyelitis who completed a full course of treatment.
What They Found
Patients who completed the full HBOT course had 7.76 times higher odds of clinical improvement compared to those who did not complete treatment. Overall improvement rates were significantly higher in the HBOT group than in historical controls.
What This Means for Canadian Patients
Chronic osteomyelitis is a debilitating bone infection that often fails conventional antibiotic and surgical treatment. This study supports completing full HBOT courses, which is relevant for Canadian patients undergoing treatment at specialized centres.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Retrospective design and selection bias in treatment completion may inflate the observed treatment effect.